dihydroxyphenylalanine has been researched along with Pigmentary Retinopathy in 2 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| OYA, T | 1 |
| KUNO, Y | 1 |
| Matsushita, K | 1 |
1 trial available for dihydroxyphenylalanine and Pigmentary Retinopathy
| Article | Year |
|---|---|
[Fundamental study on the treatment of retinitis pigmentosa].
Topics: Adolescent; Adult; Aged; Amino Acids; Animals; Antidotes; Anura; Clinical Trials as Topic; Dihydroxy | 1969 |
1 other study available for dihydroxyphenylalanine and Pigmentary Retinopathy
| Article | Year |
|---|---|
[Etiology and treatment of retinitis pigmentosa. XI. Clinical results with alpha-methyl-DOPA].
Topics: Dihydroxyphenylalanine; Humans; Methyldopa; Retinitis Pigmentosa | 1963 |